Ledger.Open graph →
SEC Form D · Amendment · filed July 17, 2025

Nia Therapeutics, Inc

Offering
$18.5M
Sold
$15.6M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
ALLSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jonathan Wachter · Allston, MADirectorDaniil Utin · Radnor, PAExecDaniel Rizzuto · San Francisco, CAExec · DirectorMilton Morris · Allston, MADirectorLarry Greenberg · Radnor, PADirectorMichael Kahana · San Francisco, CAExec · DirectorJonathan Wachter · Allston, MADirectorDaniil Utin · Radnor, PAExecDaniel Rizzuto · Radnor, PAExec · DirectorMilton Morris · Allston, MADirectorLarry Greenberg · San Francisco, CADirectorMichael Kahana · San Francisco, CAExec · DirectorShiou Lin Sam · Boston, MADirectorRonald F. Valenta · Pasadena, CAExecCharles E. Barrantes · Pasadena, CAExec · DirectorJohn O. Johnson · Pasadena, CADirectorChristopher A. Wilson · Pasadena, CADirectorDavid Connell · Pasadena, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗